New hope for depressed youth? drug trial seeks answers
NCT ID NCT02129751
Summary
This study aims to find out if bupropion, an antidepressant medication, is effective and safe for treating major depression in children and adolescents aged 7 to 17. About 246 young people with depression will receive either the real medication or a placebo (inactive pill) for several weeks. Researchers will measure changes in depression symptoms and monitor for side effects to determine if the treatment helps.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.